npj Precision Oncology is a new open-access journal committed to publishing cutting edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine.
This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years ...
research and review articles gathers the latest research on precision oncology. It focuses on how precision oncology has shaped advances in the impact of non-coding RNAs in epigenetics and cancer, immunotherapy and tumor biology, and the clinical significance of various therapies in a range of ...
Regional disparities may be creating inequities in precision oncology, which warrant immediate action, including decentralization of clinical trials.doi:10.1200/jco.2023.41.16_suppl.3113Y. UeharaT. KoyamaY. KatsuyaJ. SatoN. YamamotoAmerican Society of Clinical OncologyJournal of Clinical Oncology...
Aberrant crypt foci (ACF) are the earliest morphologically identifiable lesions in the colon that can be detected by high-definition chromoendoscopy with contrast dye spray. Although frequently associated with synchronous adenomas, their role in colorect
Pancreatic ductal adenocarcinoma (PDAC) presents a fatal clinical challenge characterized by a dismal 5-year overall survival rate, primarily due to the lack of early diagnosis and limited therapeutic efficacy. Immunotherapy, a proven success in multiple
“precision oncology” was used to describe targeting tumor molecular abnormalities with drugs known to inhibit the function of a molecular alteration. In recent years, precision oncology has included the development of therapeutic agents that target any biological abnormality that is associated with ...
A phase I trial and pharmacokinetic study of gefitinib in pediatric patients with refractory solid tumors: A Children's Oncology Group Study Gefitinib (ZD1839, Iressa), an orally active inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, is indicated in adults with refractory ...
Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancerRay O. Bahado-Singh, Amin Ibrahim, Zaid Al-Wahab, Buket Aydas, Uppala Radhakrishna, Ali Yilmaz & Sangeetha Vishweswaraiah Scientific Reports volume...
npj Precision Oncology volume 7, Article number: 78 (2023) Cite this article 9765 Accesses 22 Citations 18 Altmetric Metrics details Abstract High-grade glioma is one of the deadliest primary tumors of the central nervous system. Despite the many novel immunotherapies currently in development, it...